Drug General Information
Drug ID
D0S0BJ
Former ID
DIB013862
Drug Name
IMCgp100
Drug Type
Monoclonal antibody
Indication Melanoma [ICD9: 172; ICD10:C43] Phase 2 [889433]
Company
Immunocore
Target and Pathway
Target(s) Melanocytes lineage-specific antigen GP100 Target Info Modulator
References
Ref 889433ClinicalTrials.gov (NCT03070392) Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.